MedTrace Logo

Sexual Functioning Study With Antidepressants

NCT00316160 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 347

Last updated 2017-05-30

No results posted yet for this study

Summary

Effects of two depression medication on sexual functioning

Conditions

  • Depressive Disorder, Major
  • Major Depressive Disorder (MDD)

Interventions

DRUG

Bupropion Hydrochloride Extended-release

DRUG

Extended-release Venlafaxine

Sponsors & Collaborators

Principal Investigators

  • GSK Clinical Trials · GlaxoSmithKline

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-09-30
Primary Completion
2005-05-31
Completion
2005-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00316160 on ClinicalTrials.gov